These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14526689)

  • 1. Population-based Pap screening in Cameroon.
    Suba EJ; Raab SS
    Acta Cytol; 2003; 47(5):948-9. PubMed ID: 14526689
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility of cytology-based cervical cancer screening in rural Cameroon.
    Robyr R; Nazeer S; Vassilakos P; Matute JC; Sando Z; Halle G; Mbakop A; Campana A
    Acta Cytol; 2002; 46(6):1110-6. PubMed ID: 12462091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer in rural India.
    Miller AB
    Nat Rev Clin Oncol; 2009 Jul; 6(7):384-5. PubMed ID: 19561634
    [No Abstract]   [Full Text] [Related]  

  • 4. Dysplasia and early neoplasia of the uterine cervix. A review.
    Briggs RM
    Obstet Gynecol Surv; 1979 Jan; 34(1):70-99. PubMed ID: 375145
    [No Abstract]   [Full Text] [Related]  

  • 5. The economics of screening.
    Stewart CJ
    Cytopathology; 1997 Jun; 8(3):211. PubMed ID: 9202898
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical cancer screening in an urban emergency department.
    Hogness CG; Engelstad LP; Linck LM; Schorr KA
    Ann Emerg Med; 1992 Aug; 21(8):933-9. PubMed ID: 1497160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?
    Atashili J; Adimora AA; Ndumbe PM; Ikomey GM; Rinas AC; Myers E; Eron J; Smith JS; Miller WC
    Cancer Epidemiol; 2012 Jun; 36(3):263-9. PubMed ID: 22047636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further analysis of the ARTISTIC trial.
    Sasieni P; Castle PE; Cuzick J
    Lancet Oncol; 2009 Sep; 10(9):841-2; author reply 842-3. PubMed ID: 19717086
    [No Abstract]   [Full Text] [Related]  

  • 9. Inadequate cervical smear: what do we do?
    Phadnis SV; Doshi JS; Ogunnaike OO; Padwick ML; Sanusi FA
    Acta Obstet Gynecol Scand; 2005 May; 84(5):486-8. PubMed ID: 15842215
    [No Abstract]   [Full Text] [Related]  

  • 10. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
    Nygård JF; Nygård M; Skare GB; Thoresen SO
    Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of high grade squamous intraepithelial lesions (HSIL) and invasive cervical cancer in patients with atypical squamous cells of undetermined significance (ASCUS) from cervical pap smears.
    Limpvanuspong B; Tangjitgamol S; Manusirivithaya S; Khunnarong J; Thavaramara T; Leelahakorn S
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):737-44. PubMed ID: 19058614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of abnormal Pap smears in a consecutive and previously unscreened population in Romania.
    Stolnicu S; Musca S; Micu D; Micu L; Moldovan C; Puscasiu L
    Int J Gynaecol Obstet; 2014 Feb; 124(2):156-9. PubMed ID: 24342425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England.
    Mount SL; Papillo JL
    Pediatrics; 1999 Mar; 103(3):539-45. PubMed ID: 10049953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries for patients. Results of Pap smears and human papillomavirus tests during cervical cancer screening.
    Ann Intern Med; 2008 Apr; 148(7):I32. PubMed ID: 18378942
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of cervical intraepithelial neoplasia in Zaria.
    Adekunle OO; Samaila MO
    Ann Afr Med; 2010; 9(3):194. PubMed ID: 20710114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Incidence of dysplasia and neoplasms in cytologically suspicious cervical erosions].
    Berliński B; Zajac M
    Wiad Lek; 1979 Dec; 32(24):1747-50. PubMed ID: 545894
    [No Abstract]   [Full Text] [Related]  

  • 17. Pap smears with reactive cellular changes: a prospective study.
    Ding DC; Hsu S; Chen SS; Hsu YH
    J Reprod Med; 2007 Oct; 52(10):938-40. PubMed ID: 17977169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Pap test in HIV-positive women].
    Carlucci M; Cimmino A; Fiore MG; Lepera A; Tantimonaco L; Ricco R
    Pathologica; 2001 Dec; 93(6):651-3. PubMed ID: 11785116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
    Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
    Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.